Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases - Test2 - elhamkhani - TriplyDB

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

http://www.wikidata.org/entity/Q26864035

about

Role of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of Atherosclerosis Reactive oxygen species at the crossroads of inflammasome and inflammation Investigating the role of nucleotide-binding oligomerization domain-like receptors in bacterial lung infection Dietary interactions with the bacterial sensing machinery in the intestine: the plant polyphenol case Recognition of Extracellular Bacteria by NLRs and Its Role in the Development of Adaptive Immunity Genetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic review Therapeutic targeting of NOD1 receptors Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients.The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.NOD-like receptors in intestinal homeostasis and epithelial tissue repair.The microbiota protects against ischemia/reperfusion-induced intestinal injury through nucleotide-binding oligomerization domain-containing protein 2 (NOD2) signaling.NLRs: Sentinels of innate immunity or cancer culprits?NOD1 and NOD2: signaling, host defense, and inflammatory disease.Involvement of neutrophil hyporesponse and the role of Toll-like receptors in human immunodeficiency virus 1 protection Analysis of the genetic basis of periodic fever with aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome.NOD1 in contrast to NOD2 functional polymorphism influence Chlamydia trachomatis infection and the risk of tubal factor infertility.Efficacy of the nucleotide-binding oligomerzation domain 1 inhibitor Nodinhibit-1 on corneal alkali burns in rats.Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance.Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli.Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus.Potential roles of nucleotide-binding oligomerization domain 2 in the pathogenesis of systemic lupus erythematosus.The versatile roles of CARDs in regulating apoptosis, inflammation, and NF-κB signaling.NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions.N-acetylcysteine and azithromycin affect the innate immune response in cystic fibrosis bronchial epithelial cells in vitro.Aggregatibacter actinomycetemcomitans outer membrane vesicles are internalized in human host cells and trigger NOD1- and NOD2-dependent NF-κB activation.The function of NOD-like receptors in central nervous system diseases.The Role of Nucleotide-Binding Oligomerization Domain-Like Receptors in Pulmonary Infection.Effects of genetic variations in the genes encoding NOD1 and NOD2 on type 2 diabetes mellitus and insulin resistance.Inductive expression of the NOD1 signalling pathway in chickens infected with Salmonella pullorum.Glutamate alleviates muscle protein loss by modulating TLR4, NODs, Akt/FOXO and mTOR signaling pathways in LPS-challenged piglets.Oxidative Stress in Oral Diseases: Understanding Its Relation with Other Systemic Diseases.Increased NOD1, but not NOD2, activity in subcutaneous adipose tissue from patients with metabolic syndrome.Crystal structure of NOD2 and its implications in human disease.Characterization of Rabbit Nucleotide-Binding Oligomerization Domain 1 (NOD1) and the Role of NOD1 Signaling Pathway during Bacterial Infection.Diversity and regulation of intrinsic β-lactamases from non-fermenting and other Gram-negative opportunistic pathogens.An update on the developing mitotic inhibitors for the treatment of non-small cell carcinoma.Allergy to betalactams and nucleotide-binding oligomerization domain (NOD) gene polymorphisms.Activation of NOD-1/JNK/IL-8 signal axis in decidual stromal cells facilitates trophoblast invasion.Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors.

P2860

Q26777991-D9CC8DB6-93C6-458D-BDE4-8C382D8EDCBA Q26830685-3CC8C2A3-8AEF-451D-A9F0-AF8E68B208E7 Q26863593-557DF4CA-01B5-4B8E-ABA7-783A8C5E4B80 Q27000798-C8BEDF70-A856-4312-8124-6C7FA5EE0757 Q27008302-79980294-10CA-4BFB-AC88-34E9DDEDE859 Q28271185-C631F842-5768-4696-99AF-BE81FBA3690A Q28676201-E660EAB4-BD98-4C73-B940-6B180BC238F5 Q31170949-4331F9F2-17A1-4470-8617-303F851F66AE Q33688960-8718FF1E-4655-4D65-83EA-43A47E237D31 Q33907548-D4A84379-26FF-41EF-B4EE-974C1ABC0F81 Q34429954-A3F1DBCF-C913-40DB-B89A-051F8B5EE8C9 Q34458453-8E23AA26-09D7-4744-9793-D86E436B0921 Q34745603-6669D025-8C95-4D82-AABB-AA6C4D301E4D Q35192491-4070EE11-1976-4557-BB15-D10EC5BCC0E0 Q35623377-7E962560-BAF5-4D91-BCE1-1BEE5416C683 Q35975520-2609CD26-4D61-4F67-90C9-16D52938B3EE Q36243072-0DC8A477-FA6F-4DFD-B852-F7E1CB0AA8AE Q37235428-2EE14F99-6121-4723-AB50-1CAFBE94E738 Q37594944-40488176-54EC-417B-83B5-D7D5C19C8858 Q38070410-CDEE3A7D-BDF7-447B-8C83-0EB69D898455 Q38182646-A7301A3E-862C-4E9A-8A49-5AAE10E06998 Q38193722-A9451B0D-1A7F-44E4-A54A-624B90D9E2B4 Q38270942-858B3F2E-330C-4E8A-A42E-5B39585C15FA Q38680628-AC744F67-887F-4484-804A-52C876EE5714 Q38972117-0DE2478D-85FE-4538-9A8E-E3AE485ADE5F Q38975332-2F23C167-1349-4BB0-BB6B-82A79BD03B7F Q39061008-E22D2937-4910-4A03-835A-206E7FA22772 Q39117827-6A28DB1F-3340-48CA-8823-1BB2E8C5B985 Q39154989-AAD5985D-E4E5-4BC4-A506-4B26D1998739 Q40373091-B8BC02A3-0E74-4E23-A393-1AFF3A98E1B5 Q41255629-0F33D6C8-97AB-493F-A974-0B6D72D721B0 Q41673383-9446D629-2DC4-4544-B421-58A77E1CE743 Q42478019-C962DE9A-8D81-4FAF-8377-7FA87CF7A218 Q42576684-2CF5D0E3-0A4C-443C-AF01-CB4BB921A3C1 Q42654147-2B2AD511-BEE4-42D9-94C4-EAB4539903B7 Q46286684-6A5468E0-4E66-4876-ABD8-D7A6AC1D0597 Q47553028-0FE7941E-62C6-405E-9C6D-1F2CA54A2376 Q47929878-970CE9AE-AC2C-47C3-BDC1-1A76431524F0 Q48093183-B69F6D68-3C1F-4F0E-BAD4-419F69D07DF3 Q48509895-DA3312AF-2DAE-4425-A9E5-F820747BFA5D

P2860

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

http://www.wikidata.org/entity/Q26864035

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

@ast

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

@en

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

@nl

type

label

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

@ast

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

@en

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

@nl

prefLabel

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

@ast

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

@en

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

@nl

P1433

Q26864035-B30C5456-30B1-492D-AA2E-37E5DE23A1A7

P1476

Q26864035-C8680984-20CE-4708-BDDD-C8C6A6740884

P2093

Q26864035-B2A1B2EB-4C73-442B-81AB-F138726E0151

Q26864035-B899C758-6176-45D0-A236-265B913F252A

Q26864035-F85969FA-DD55-4846-AD55-27609AA32931

P275

Q26864035-AE75A8C2-87D3-46E3-86ED-6438ABB4B5CE

P2860

Q26864035-02EBBF11-EB37-48D0-A70A-A247BEE80920

Q26864035-03BC22C3-C61F-4D54-8EA9-747940609A6C

Q26864035-0B34732F-6A49-4ECB-A9F0-364C06ED8283

Q26864035-0C6846AA-7D4C-4A3D-B8AE-158E0CDFD64E

Q26864035-15C9E872-F9EB-4601-BD94-8ECECF5F53BA

Q26864035-1882F296-D483-491C-9575-AD5D396C620D

Q26864035-1B750D75-B7B9-4B17-A8CA-12EAA7A2507D

Q26864035-1CAF6232-C9E0-4A9A-B7A2-703AFC97970F

Q26864035-1E535646-B27B-4714-A318-60A57FEAF4FB

Q26864035-1FFA87A8-379D-4F9C-9B80-D59161B4787A

P304

Q26864035-E2F26093-7E71-4732-A2A3-6A029DAA6892

P31

Q26864035-2E5D6C4B-0DA7-4BD6-A951-0E6B17E93698

Q26864035-563464C8-4BAB-4356-975C-84E9101B5AA4

P3181

Q26864035-C1E3C4B0-978A-46A8-9900-9CA557074063

P356

Q26864035-6EA83251-455C-4C11-82EC-2E069E07BB51

P407

Q26864035-E59CCAF3-27EE-4B4E-B0BA-0B59398D7628

P433

Q26864035-B5CE170B-DBDE-4397-9A65-F6B34FAF736F

P478

Q26864035-BCB2EC30-5ABA-4BB5-B6E6-6245EDB533B5

P577

Q26864035-AE588B1F-6358-4F54-A27B-88676C65A99E

Q26864035-C6A8A032-DF63-490E-AEBE-1EA793801DB5

P5875

Q26864035-FBE4756B-7874-48AF-AB34-57BC366E1DB2

P698

Q26864035-5BE52AFD-5FE9-4652-88BC-0AEF6ED07B37

P921

Q26864035-D4379A9D-6835-409D-99B7-AEA091370B6F

Q26864035-EC14F123-F7A1-4B16-BD0A-EC9D19543552

Q26864035-F97421FB-D404-496D-87FF-195670CDFC8B

P932

Q26864035-A4E9F7C3-EA5F-4BCE-8721-6BB3B00DECCA

P3181

P356

P1433

Bioscience Reports

P1476

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

@en

P2093

John C. Reed

http://www.w3.org/2001/XMLSchema#string

Ricardo G. Correa

http://www.w3.org/2001/XMLSchema#string

Snezana Milutinovic

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP

Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB

Finding NEMO by K63-linked polyubiquitin chain

Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1

BID: a novel BH3 domain-only death agonist

The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO

P304

597-608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

884004

http://www.w3.org/2001/XMLSchema#string

P356

10.1042/BSR20120055

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230712942

http://www.w3.org/2001/XMLSchema#string

P698

22908883

http://www.w3.org/2001/XMLSchema#string

P921

transport protein

P932

3497720

http://www.w3.org/2001/XMLSchema#string